ubenimex has been researched along with B16 Melanoma in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koizumi, K; Minami, T; Saiki, I; Saitoh, Y; Sakurai, H; Sekine, K | 1 |
| Carmona, AK; Juliano, L; Juliano, MA; Monteiro, HP; Oliveira, V; Paschoalin, T; Rodrigues, EG; Travassos, LR | 1 |
| Belowski, D; Herman, ZS; Kowalski, J; Madej, A | 1 |
| Fujimoto, Y; Hashimoto, Y; Kadoya, S; Kagechika, H; Kato, F; Kato, M; Koiso, Y; Komoda, M; Miyata, K; Takayama, H | 1 |
| Abe, F; Black, PL; Pelus, LM; Talmadge, JE | 2 |
| Abe, F; Black, PL; Schneider, M; Talmadge, JE | 1 |
| Abe, F; Alvord, G; Koyama, M; Matsuda, A; Talmadge, JE | 1 |
8 other study(ies) available for ubenimex and B16 Melanoma
| Article | Year |
|---|---|
A derivative of aminopeptidase inhibitor (BE15) has a dual inhibitory effect of invasion and motility on tumor and endothelial cells.
Topics: Aminopeptidases; Animals; Antibiotics, Antineoplastic; Capillaries; Cell Line; Cell Movement; Cell Survival; Endothelial Cells; Extracellular Matrix; Humans; Leucine; Melanoma, Experimental; Mice; Neoplasm Invasiveness; Neoplasms; Protease Inhibitors; Wound Healing | 2006 |
Characterization of thimet oligopeptidase and neurolysin activities in B16F10-Nex2 tumor cells and their involvement in angiogenesis and tumor growth.
Topics: Angiogenic Proteins; Animals; Antineoplastic Agents; Bradykinin; Cell Extracts; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Cloning, Molecular; Coculture Techniques; Collagen; Culture Media, Conditioned; Dipeptides; Dose-Response Relationship, Drug; Drug Combinations; Endothelial Cells; Female; Hydrolysis; Laminin; Leucine; Melanoma, Experimental; Metalloendopeptidases; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Neurotensin; Nitric Oxide; Nitric Oxide Donors; Oligopeptides; Peptides; Phenanthrolines; Protease Inhibitors; Proteoglycans; S-Nitroso-N-Acetylpenicillamine; Substrate Specificity | 2007 |
Antitumor activity of bestatin and thiorphan in mice.
Topics: Animals; Antineoplastic Agents; Drug Synergism; Female; Killer Cells, Natural; Leucine; Macrophages; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Naloxone; Protease Inhibitors; Thiorphan | 1995 |
Potent homophthalimide-type inhibitors of B16F10/L5 mouse melanoma cell invasion.
Topics: Aminopeptidases; Animals; Antineoplastic Agents; Enzyme Inhibitors; Humans; Hydroxamic Acids; Isoquinolines; Leucine; Melanoma, Experimental; Mice; Neoplasm Invasiveness; Tumor Cells, Cultured | 1999 |
Hematopoietic and therapeutic properties of bestatin in normal and myelosuppressed mice.
Topics: Animals; Antibiotics, Antineoplastic; Bone Marrow Diseases; Cyclophosphamide; Drug Therapy, Combination; Female; Hematopoiesis; Hematopoietic Stem Cells; Leucine; Melanoma, Experimental; Mice; Mice, Inbred C57BL | 1991 |
Hematopoietic and hematologic properties of bestatin in normal and cyclophosphamide myelosuppressed mice.
Topics: Aminopeptidases; Animals; Bone Marrow; Cell Count; Cyclophosphamide; Drug Therapy, Combination; Hematopoietic Stem Cells; Immune Tolerance; Leucine; Lung Neoplasms; Melanoma, Experimental; Mice | 1990 |
Chemoimmunotherapy with cyclophosphamide and bestatin in experimental metastasis in mice.
Topics: Adjuvants, Immunologic; Animals; Combined Modality Therapy; Cyclophosphamide; Cytotoxicity, Immunologic; Immunity, Cellular; Killer Cells, Natural; Leucine; Lymphoma; Macrophages; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms, Experimental | 1989 |
Pharmacokinetics of bestatin and oral activity for treatment of experimental metastases.
Topics: Administration, Oral; Animals; Antibiotics, Antineoplastic; Drug Administration Schedule; Injections, Intravenous; Leucine; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL | 1989 |